Biological treatment in resistant adult-onset Still's disease: A single-center, retrospective cohort study.

Biological drugs seem to be effective for AOSD patients who are resistant to conventional therapies. Due to the administration methods and the high costs of these drugs, however, tapering the treatment should be considered, after remission is achieved.